Diabetes care is evolving fast. This roundup brings you 12 must-read updates. We cover emotional barriers, policy shifts, cutting-edge treatments, and real-life stories. Read on to stay informed and empowered.
Breaking Barriers: Patient Fear and Access
Fear can block healing. A piece from diabetesincontrol.com explains how anxiety around needles, diagnosis, and costs leads to missed visits and skipped tests. Providers can help by asking open questions, validating feelings, and offering peer support. That trust lifts barriers to better blood sugar control.
Across the globe, access issues persist. In New Zealand, a new 12-month prescription plan aims to cut costs and paperwork. But doctors warn that fewer checkups may risk seriously ill patients. The Economic Times reports that three-month refills may not catch rising A1C or kidney trouble in time.
Closer to home, advocacy rises for early screening. New York legislators want Asian Americans tested for diabetes at a BMI of 23, not 25. The move, backed by the NY Senate, could catch cases sooner in high-risk groups. No co-pays at BMI 23 mean fewer cost worries and more timely care.
Innovations in Treatment
New therapies continue to emerge. A study from ntd.com shows GLP-1 receptor agonists cut obesity-related cancer risk by 7% and all-cause death by 8%, compared to DPP-4 drugs. This suggests benefits beyond blood sugar control.
But GLP-1 drugs can be pricey for non-diabetic patients. Dakota News Now reports monthly costs of $500 to $1,000 out-of-pocket. That has doctors seeking lower-cost options and mental health support to tackle weight issues at the root.
On the horizon is orforglipron, an oral GLP-1 agonist. A 40-week trial showed A1C drops of 1.3%–1.6% and average weight loss of 16 lbs. Read more at Pharmacy Times. If approved in 2026, it could offer a pill alternative to injectables.
For eye health, combination therapy for diabetic retinopathy is promising. Patients on ranibizumab plus dexamethasone faced fewer cases of macular edema and saw better vision, reports HCPLive. Now retina specialists can tailor treatment to reduce visits and costs.
And the FDA approved Susvimo 100 mg/mL, a refillable eye implant for retinopathy. With one refill every nine months, patients avoid monthly injections. Learn about the Phase III results and how Susvimo maintains vision with less hassle.
Research Advances
At the Max Delbrück Center, scientists built a vascularized stem cell islet model. These organoids act more like real pancreatic islets, with mature beta cells and higher insulin output. See the full report.
Hypoglycemia may worsen retinopathy via HIF accumulation in retinal cells. Researchers found that low sugar spikes trigger HIF-dependent mediators that leak blood vessels. Reducing HIF could guard against early retinopathy, according to Nature.
Long-term blood pressure matters too. A study in Cardiovascular Diabetology shows that SBP under 120 mmHg best predicts lower arterial stiffness and fewer diabetic kidney disease cases. Tracking cumulative load helps pinpoint patients needing tighter control.
Frailty links to type 2 diabetes through a distinct metabolome. UK Biobank data finds 53 key metabolites mediate a third of the frailty-T2D risk. Add genetic scores and the risk jumps. Study details at Cardiovascular Diabetology.
For neuropathy, vitamin B12 acupoint injections improve nerve conduction more than standard doses. A meta-analysis of 20 trials found better motor and sensory speeds without more side effects. Read the meta-analysis.
Community and Support
High school senior Addy White didn’t miss graduation after a sudden type 1 diagnosis. Nurses pushed for her to join the ceremony safely, as told by NewsOn6. Her story shows the power of care teams.
On June 14, Ravenswood hosts the Dash for Diabetes 5K. Registration at newsandsentinel.com supports healthy habits and raises awareness. Fees are $10–$25, and same-day sign-up starts at 7 a.m.
Living Well Tips
Why does neuropathy hurt more at night? Experts at Mass General Brigham point to lower body temp, less movement, and fewer natural pain blockers. Warm socks, good sleep hygiene, and timed meds can soothe pain.
Even an isometric handgrip boost reveals gaps. A trial showed diabetics have less blood flow and higher heart rates than others during grip exercises. Simple workouts may need tweaks. Check the Cureus study for guidance.
The Saudi diabetic food market is growing but faces high costs for premium ingredients. Innovations in low-calorie sweeteners and fiber-rich foods are on the rise. Read the strategies at GlobeNewswire.
Call to Action
Got extra test strips or unopened supplies? Turn them into cash. DiabeticSupplies.Online is the best place to sell unused diabetic supplies. Get a quote, ship for free, and get paid fast. Join thousands of others who trust us to handle their medical diabetic supplies.
FAQ – People Also Ask
How do I address fear of hypoglycemia?
Start by talking with your provider about your worries. Peer support groups and trauma-informed care can help you feel safe. Setting clear goals and using open-ended questions can uncover hidden fears.
What is the benefit of vascularized stem cell islets?
They mimic real pancreatic tissue. The added blood vessels boost beta cell maturity and insulin release. Researchers can study diabetes and test new cell therapies more accurately.
Can oral GLP-1 drugs replace injections?
Orforglipron shows promise by lowering A1C by up to 1.6% and supporting weight loss. It could offer a pill option, but FDA approval is pending.
Where can I sell unused diabetic test strips?
DiabeticSupplies.Online buys test strips and many diabetic supplies for cash by mail. Free shipping labels and fast payments make it easy.
How often should diabetics get eye implants like Susvimo?
Susvimo requires a refill every nine months. It delivers continuous ranibizumab, reducing the need for monthly injections and frequent clinic visits.